A patent ductus arteriosus (PDA) is a persistent connection between the aorta and the pulmonary artery resulting in left to right shunting. This connection is supposed to close shortly after birth ...

Cite this: Current Controversies in the Diagnosis and Treatment of Patent Ductus Arteriosus in Preterm Infants - Medscape - Aug 01, 2003. The DA of a very preterm infant has minimal constriction ...

Merit Medical Systems has enrolled the first patient in the multi-centre PREEMIE study to assess the efficacy and safety of the Bloom Micro Occluder System, aimed at treating patent ductus arteriosus ...

Merit Medical Systems, Inc. MMSI, on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus ...

prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants (PREEMIE study). PDA is a congenital heart condition that occurs when ...

Although patent ductus arteriosus (PDA) leading to significant hemodynamic changes in premature babies can be cured by medical or surgical methods, debate is ongoing about the selection of the ...

Background: Recent studies have demonstrated that platelet count (PLTc) and function have an important role in promoting spontaneous closure of the PDA in animal models. Aimto evaluate whether ...

The Uganda Heart Institute (UHI) has successfully performed five closed-heart surgeries - free of charge — to correct Patent Ductus Arteriosus (PDA), a congenital heart defect. Every year ...

Widened pulse pressure is commonly used clinically to evaluate for PDA. However, this clinical sign also does not withstand critical evaluation. Evans et al found no difference in pulse pressure ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder ...